These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17768034)

  • 1. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.
    Roveta S; Schito AM; Marchese A; Schito GC
    Int J Antimicrob Agents; 2007 Nov; 30(5):415-21. PubMed ID: 17768034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Chemother; 2004 Feb; 16(1):30-7. PubMed ID: 15077996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.
    Soussy CJ; Nguyen J; Goldstein F; Dabernat H; Andremont A; Leclercq R; Drugeon H; Cavallo P; Chardon H; Etienne J; Rio Y; Courvalin P
    Clin Microbiol Infect; 2003 Oct; 9(10):997-1005. PubMed ID: 14616741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin and biofilm production by coagulase-negative staphylococci.
    Pérez-Giraldo C; Gonzalez-Velasco C; Sánchez-Silos RM; Hurtado C; Blanco MT; Gómez-García AC
    Chemotherapy; 2004 Jun; 50(2):101-4. PubMed ID: 15211086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.
    Elshafie SS; Al-Kuwari J
    Int J Antimicrob Agents; 2004 Sep; 24(3):309-10. PubMed ID: 15325441
    [No Abstract]   [Full Text] [Related]  

  • 12. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae.
    Wang D; Wang Y; Liu YN
    Chin Med J (Engl); 2009 Jun; 122(11):1305-10. PubMed ID: 19567142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.
    Decousser JW; Allouch PY; Courvalin P; Leclercq R;
    Int J Antimicrob Agents; 2002 Sep; 20(3):186-95. PubMed ID: 12385697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of fluoroquinolones on urological infection pathogens within biofilms].
    Tets VV; Artemenko NK; Zaslavskaia NV; Tets GV
    Urologiia; 2010; (1):13-7. PubMed ID: 20891043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C
    Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections.
    Hicks PS; Pelak B; Woods GL; Bartizal KF; Motyl M
    Clin Microbiol Infect; 2002 Nov; 8(11):753-7. PubMed ID: 12445016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro.
    Ulrich M; Berger J; Möller JG; Döring G
    Infection; 2005 Dec; 33 Suppl 2():50-4. PubMed ID: 16518712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm.
    Wei GX; Campagna AN; Bobek LA
    J Antimicrob Chemother; 2006 Jun; 57(6):1100-9. PubMed ID: 16595638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.